NYSE:KOP - Koppers Stock Price, Forecast & News

Koppers trades on the New York Stock Exchange (NYSE) under the ticker symbol "KOP."

Koppers Holdings Inc. (NYSE:KOP) posted its quarterly earnings data on Thursday, November, 7th. The specialty chemicals company reported $1.24 EPS for the quarter, beating the Zacks' consensus estimate of $0.97 by $0.27. The specialty chemicals company had revenue of $474.90 million for the quarter, compared to analyst estimates of $485.13 million. Koppers had a net margin of 2.40% and a return on equity of 81.83%. The business's revenue for the quarter was up 7.3% on a year-over-year basis. During the same quarter last year, the business earned $0.73 earnings per share. View Koppers' Earnings History.

Koppers is scheduled to release their next quarterly earnings announcement on Friday, March 6th 2020. View Earnings Estimates for Koppers.

Koppers updated its FY 2019 Pre-Market earnings guidance on Monday, November, 25th. The company provided earnings per share guidance of $3.35-3.55 for the period, compared to the Thomson Reuters consensus estimate of $3.39. The company issued revenue guidance of $$1.8-1.8 billion, compared to the consensus revenue estimate of $$1.83 billion.

2 brokers have issued 12 month target prices for Koppers' shares. Their forecasts range from $45.00 to $50.00. On average, they expect Koppers' stock price to reach $47.50 in the next twelve months. This suggests a possible upside of 47.6% from the stock's current price. View Analyst Price Targets for Koppers.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Koppers in the last year. There are currently 1 sell rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Koppers.

News coverage about KOP stock has trended somewhat negative recently, InfoTrie Sentiment Analysis reports. InfoTrie ranks the sentiment of press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Koppers earned a media sentiment score of -1.4 on InfoTrie's scale. They also gave media stories about the specialty chemicals company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for Koppers.

Koppers saw a increase in short interest during the month of January. As of January 15th, there was short interest totalling 510,400 shares, an increase of 16.6% from the December 31st total of 437,800 shares. Based on an average daily trading volume, of 178,800 shares, the short-interest ratio is presently 2.9 days. Approximately 2.6% of the shares of the stock are short sold. View Koppers' Current Options Chain.

Some companies that are related to Koppers include LyondellBasell Industries (LYB), Westlake Chemical (WLK), CHURCHILL CAP C/SH (CCC), Cabot (CBT), Kronos Worldwide (KRO), Tredegar (TG), Hawkins (HWKN) and Trecora Resources (TREC).

Based on aggregate information from My MarketBeat watchlists, some companies that other Koppers investors own include Alcoa (AA), CVS Health (CVS), Intel (INTC), Micron Technology (MU), Starbucks (SBUX), AbbVie (ABBV), Alibaba Group (BABA), Verizon Communications (VZ), Century Aluminum (CENX) and Bank of America (BAC).

Koppers' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include California Public Employees Retirement System (0.49%), New York State Teachers Retirement System (0.21%), Bowling Portfolio Management LLC (0.16%), Zeke Capital Advisors LLC (0.11%), Strs Ohio (0.09%) and Arizona State Retirement System (0.07%). Company insiders that own Koppers stock include Albert J Neupaver, Bradley A Pearce, Christian A Nielsen, Cynthia A Baldwin, Daniel R Groves, Fleetwood S Hassell, James A Sullivan, Jianzhong Zhu, Joseph P Dowd, Leslie S Hyde, Louann E Tronsberg-Deihle, M Leroy Ball, Mark R Mccormack, Michael Zugay, R Michael Johnson, Stephen C Reeder, Steven R Lacy, Thomas D Loadman and Xudong Feng. View Institutional Ownership Trends for Koppers.

KOP stock was sold by a variety of institutional investors in the last quarter, including Arizona State Retirement System, Zeke Capital Advisors LLC, AE Wealth Management LLC, Wakefield Asset Management LLLP and Louisiana State Employees Retirement System. Company insiders that have sold Koppers company stock in the last year include Bradley A Pearce, Leslie S Hyde, Steven R Lacy and Xudong Feng. View Insider Buying and Selling for Koppers.

KOP stock was purchased by a variety of institutional investors in the last quarter, including California Public Employees Retirement System, Bowling Portfolio Management LLC, Strs Ohio, Dupont Capital Management Corp, OmniStar Financial Group Inc., New York State Teachers Retirement System, Miles Capital Inc. and Harel Insurance Investments & Financial Services Ltd.. Company insiders that have bought Koppers stock in the last two years include Albert J Neupaver, Fleetwood S Hassell, James A Sullivan, M Leroy Ball, Michael Zugay and R Michael Johnson. View Insider Buying and Selling for Koppers.

Shares of KOP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of KOP stock can currently be purchased for approximately $32.19.

Koppers has a market capitalization of $666.27 million and generates $1.71 billion in revenue each year. The specialty chemicals company earns $23.40 million in net income (profit) each year or $3.50 on an earnings per share basis. Koppers employs 2,229 workers across the globe.View Additional Information About Koppers.

The official website for Koppers is http://www.koppers.com/.

Koppers' mailing address is 436 SEVENTH AVENUE, PITTSBURGH PA, 15219. The specialty chemicals company can be reached via phone at 412-227-2001 or via email at [email protected]